Literature DB >> 16285670

Reliability of human serum protein profiles generated with C8 magnetic beads assisted MALDI-TOF mass spectrometry.

Mirre E de Noo1, Rob A E M Tollenaar, Aliye Ozalp, Peter J K Kuppen, Marco R Bladergroen, Paul H C Eilers, André M Deelder.   

Abstract

Protein profiling with mass spectrometry is a promising approach for classification and identification of biomarkers; however, there is debate about measurement quality and reliability. Here, we present a pipeline for preprocessing, statistical data analysis and presentation. Serum samples of 16 healthy individuals are used to generate protein profiles with high-resolution MALDI-TOF after isolation of peptides with C8 magnetic beads. Analysis of variance was performed after binning, baseline correction and normalization of the mean spectra. Relative variations in the spectra are expressed as coefficient of variation, which depending on the respective preanalytical variation parameter investigated, was found to range between 0.15 and 0.67 in this study. With this novel method, the reproducibility of our protein profiling procedure could be quantified. We showed that circadian rhythm and the number of freeze-thaw cycles had relatively limited influence on serum protein profiles, whereas the period between collection and serum centrifugation had a more pronounced effect.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16285670     DOI: 10.1021/ac050571f

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  19 in total

1.  Quality control based on isotopic distributions for high-throughput MALDI-TOF and MALDI-FTICR serum peptide profiling.

Authors:  Simone Nicolardi; Magnus Palmblad; Hans Dalebout; Marco Bladergroen; Rob A E M Tollenaar; André M Deelder; Yuri E M van der Burgt
Journal:  J Am Soc Mass Spectrom       Date:  2010-05-12       Impact factor: 3.109

Review 2.  Biomarkers discovery by peptide and protein profiling in biological fluids based on functionalized magnetic beads purification and mass spectrometry.

Authors:  Fulvio Magni; Yuri E M Van Der Burgt; Clizia Chinello; Veronica Mainini; Erica Gianazza; Valeria Squeo; André M Deelder; Marzia Galli Kienle
Journal:  Blood Transfus       Date:  2010-06       Impact factor: 3.443

3.  Serum biomarker profiling by solid-phase extraction with particle-embedded micro tips and matrix-assisted laser desorption/ionization mass spectrometry.

Authors:  Arti Navare; Manshui Zhou; John McDonald; Fernando G Noriega; M Cameron Sullards; Facundo M Fernandez
Journal:  Rapid Commun Mass Spectrom       Date:  2008-04       Impact factor: 2.419

4.  Detection of pancreatic cancer using serum protein profiling.

Authors:  Berit Velstra; Bert A Bonsing; Bart J Mertens; Yuri E M van der Burgt; Anouck Huijbers; Hans Vasen; Wilma E Mesker; André M Deelder; Rob A E M Tollenaar
Journal:  HPB (Oxford)       Date:  2012-11-30       Impact factor: 3.647

Review 5.  Current status and prospects of clinical proteomics studies on detection of colorectal cancer: hopes and fears.

Authors:  M E de Noo; R A E M Tollenaar; A M Deelder; L H Bouwman
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

6.  Enrichment and detection of molecules secreted by tumor cells using magnetic reversed-phase particles and LC-MALDI-TOF-MS.

Authors:  Jochen F Peter; Angela M Otto; Bernhard Wolf
Journal:  J Biomol Tech       Date:  2007-12

7.  Serum peptide signatures for pancreatic cancer based on mass spectrometry: a comparison to CA19-9 levels and routine imaging techniques.

Authors:  Berit Velstra; Marieke A Vonk; Bert A Bonsing; Bart J Mertens; Simone Nicolardi; Anouck Huijbers; Hans Vasen; André M Deelder; Wilma E Mesker; Yuri E M van der Burgt; Rob A E M Tollenaar
Journal:  J Cancer Res Clin Oncol       Date:  2014-09-21       Impact factor: 4.553

8.  Improved classification of breast cancer peptide and protein profiles by combining two serum workup procedures.

Authors:  Berit Velstra; Yuri E M van der Burgt; Bart J Mertens; Wilma E Mesker; André M Deelder; Rob A E M Tollenaar
Journal:  J Cancer Res Clin Oncol       Date:  2012-07-05       Impact factor: 4.553

Review 9.  The proteomics big challenge for biomarkers and new drug-targets discovery.

Authors:  Rocco Savino; Sergio Paduano; Mariaimmacolata Preianò; Rosa Terracciano
Journal:  Int J Mol Sci       Date:  2012-10-29       Impact factor: 5.923

10.  An automated plasma protein fractionation design: high-throughput perspectives for proteomic analysis.

Authors:  Claudia Boccardi; Silvia Rocchiccioli; Antonella Cecchettini; Alberto Mercatanti; Lorenzo Citti
Journal:  BMC Res Notes       Date:  2012-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.